Browsing by Author "Januarie, Kaylin Cleo"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item L-Cysteine-Capped Indium Telluriselenide Quantum Dot Aptasensor for Interferon-Gamma TB Biomarker(University of the Western Cape, 2018) Januarie, Kaylin Cleo; Iwuoha, EmmanuelTuberculosis (TB) is one of the major infectious diseases that affect the health of people all over the world. South Africa is one of the countries that account for most of the TB cases; it is the leading cause of death in South Africa and is known to be lethal when combined with HIV in patients. Various tests have been used to diagnose tuberculosis infected patients, but some of these tests give false positive results. Studies have shown that tuberculosis-related cytokines can serve as biological markers for the diagnosis of TB. Cytokines are signalling proteins secreted by immune cells and one such cytokine is interferon-gamma (IFN-?). Interferon-gamma is secreted by immune cells in response to various pathogens and has many physiological roles in the immune system and inflammatory stimuli. IFN-? was first detected using antibody-based immunosensing techniques but this approach is expensive, time consuming and has low stability, it is therefore vital that an alternative detection method for IFN-? be developed.Item Recent advances in the detection of interferon‑gamma as a TB biomarker(Springer, 2021) Januarie, Kaylin Cleo; Uhuo, Onyinyechi V.; Iwuoha, EmmanuelTuberculosis (TB) is one of the main infectious diseases worldwide and accounts for many deaths. It is caused by Mycobacterium tuberculosis usually afecting the lungs of patients. Early diagnosis and treatment are essential to control the TB epidemic. Interferon-gamma (IFN-γ) is a cytokine that plays a part in the body’s immune response when fghting infection. Current conventional antibody-based TB sensing techniques which are commonly used include enzyme-linked immunosorbent assay (ELISA) and interferon-gamma release assays (IGRAs). However, these methods have major drawbacks, such as being time-consuming, low sensitivity, and inability to distinguish between the diferent stages of the TB disease. Several electrochemical biosensor systems have been reported for the detection of interferon-gamma with high sensitivity and selectivity. Microfuidic techniques coupled with multiplex analysis in regular format and as lab-on-chip platforms have also been reported for the detection of IFN-γ. This article is a review of the techniques for detection of interferon-gamma as a TB disease biomarker. The objective is to provide a concise assessment of the available IFN-γ detection techniques (including conventional assays, biosensors, microfuidics, and multiplex analysis) and their ability to distinguish the diferent stages of the TB disease.